Evidence map›Paper›PMID 42726543›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Carbon Quantum Dots as a Luminescent Platform for Photoswitchable Bioactive Hybrids: Tuning Butyrylcholinesterase Inhibition Through Functional Group Engineering.

Ilya Kolesnikov, Gulia Bikbaeva, Anastasia Egorova, Anna Pilip, Aleksandra Levshakova, Kirill Laptinskiy, Alexey Vervald, Tatiana Dolenko, Xiaojun Han, Alina A Manshina

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ilya KolesnikovSt. Petersburg State University, 7-9 Universitetskaya Embankment, St. Petersburg 199034, Russia.
Gulia BikbaevaSt. Petersburg State University, 7-9 Universitetskaya Embankment, St. Petersburg 199034, Russia.
Anastasia EgorovaSt. Petersburg State University, 7-9 Universitetskaya Embankment, St. Petersburg 199034, Russia.ORCID 0000-0002-0057-4202
Anna PilipSt. Petersburg State University, 7-9 Universitetskaya Embankment, St. Petersburg 199034, Russia.
Aleksandra LevshakovaSt. Petersburg State University, 7-9 Universitetskaya Embankment, St. Petersburg 199034, Russia.ORCID 0000-0001-8164-5174
Kirill LaptinskiyM.V. Lomonosov Moscow State University, Moscow 119991, Russia.ORCID 0000-0003-2592-5942
Alexey VervaldM.V. Lomonosov Moscow State University, Moscow 119991, Russia.ORCID 0000-0002-3789-2191
Tatiana DolenkoM.V. Lomonosov Moscow State University, Moscow 119991, Russia.ORCID 0000-0003-2884-8241
Xiaojun HanHeilongjiang Provincial Joint Laboratory of Molecular Science (International Cooperation), School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China.ORCID 0000-0001-8571-6187
Alina A ManshinaSt. Petersburg State University, 7-9 Universitetskaya Embankment, St. Petersburg 199034, Russia.ORCID 0000-0002-1053-6410

Funding

Russian Science Foundation 22-13-00082-П
6 · The paper itself

Abstract

Light-responsive materials enabling external modulation of bioactivity and spatial control are highly requested for photopharmacology-a booming research area of modern medicine. We present organo-inorganic hybrids of photoswitchable, bioactive symmetric diamine-phosphine oxides conjugated with luminescent carbon quantum dots (CQDs). The phosphonate compound was found to undergo

Indexed as

butyrylcholinesterase inhibitioncarbon quantum dotsluminescencemultifunctional materialsphotoactivation of bioactivityphotopharmacology

Identifiers

PMID42726543
PMCPMC13567531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.